1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
|
|
- CAS号:
- 143797-63-1
- 英文名:
- SB 200646 HYDROCHLORIDE
- 英文别名:
- SB 200646;SB200646HCl;SB 200646 HYDROCHLORIDE;N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea;N-(1-Methyl-1H-indol-5-yl)-N'-3-pyridinylurea;1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-yl-urea;Urea, N-(1-methyl-1H-indol-5-yl)-N'-3-pyridinyl-;N-(1-METHYL-1H-INDOL-5-YL)-N'-3-PYRIDINYLUREA HYDROCHLORIDE;N-(1-METHYL-1H-5-INDOLYL)-N'-(3-PYRIDINYL)UREA HYDROCHLORIDE;electrophysiological,5-HT Receptor,SNC,Serotonin Receptor,Inhibitor,antipsychotic,inhibit,5-hydroxytryptamine Receptor,5-HT2B,SB200646,anxiolytic,5-HT2C,neurons,SB 200646,dopaminergic,SB-200646
- 中文名:
- 1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
- 中文别名:
- 化合物SB-200646;1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
- CBNumber:
- CB7234079
- 分子式:
- C15H14N4O
- 分子量:
- 266.3
- MOL File:
- 143797-63-1.mol
|
|
|
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲化学性质
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: ~26 mg/mL, soluble
-
|
-
形态:
-
solid
-
|
-
颜色:
-
pale yellow
-
|
-
水溶解性:
-
Water: 1 mg/mL (NaN mM)
-
|
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲性质、用途与生产工艺
SB 200646 (SB 200646A) 是一种强效的、选择性的 5-HT2B/2C 口服活性拮抗剂,比对5-HT2A受体的选择性高出50倍。SB 200646 对大鼠 5-HT2C 受体、大鼠 5-HT2B 受体和大鼠 5-HT2A 受体的pKi值分别为6.9、7.5和5.2。SB 200646 在体内具有电生理作用和抗焦虑的特性。
Target | Value |
5-HT2B (rat)
(Cell-free assay)
|
7.5(pKi)
|
5-HT2C (Rat)
(Cell-free assay)
|
6.9(pKi)
|
5-HT2A (rat)
(Cell-free assay)
|
5.2(pKi)
|
SB-200646A (4 μM) abolishes the ethanol-induced increase in miniature inhibitory postsynaptic current (mIPSC) frequency and had no effect on basal mIPSC frequency.
SB-200646A (20 mg/kg; intravenous injection; daily; for 21 days; male albino Sprague-Dawley rats) treatment significantly decreases the number of spontaneously active ventral tegmental area (VTA) dopaminergic neurons.
The i.v. administration of 4-16 mg/kg of SB-200646A significantly increases the firing rate and % events as bursts in spontaneously active VTA dopaminergic neurons and significantly increases the % events as burst in substantia nigra pars compacta (SNC) dopaminergic neurons.
Animal Model:
|
Male albino Sprague-Dawley rats (200-225 g at the beginning of treatment and 300-350 g at the time of the experiment)
|
Dosage:
|
20 mg/kg
|
Administration:
|
Intravenous injection; daily; for 21 days
|
Result:
|
Significantly decreased the number of spontaneously active ventral tegmental area (VTA) dopaminergic neurons.
|
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | S2649 | 1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲 SB 200646 | 143797-63-1 | 5mg | 2246.13元 |
2024/04/30 | S2649 | 1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲 SB 200646 | 143797-63-1 | 25mg | 7366.54元 |
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
生产厂家
143797-63-1, 1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲 相关搜索:
- 药靶配体
- C15H14N4OHCl
- 化合物SB-200646
- 1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲
- 143797-63-1
- electrophysiological,5-HT Receptor,SNC,Serotonin Receptor,Inhibitor,antipsychotic,inhibit,5-hydroxytryptamine Receptor,5-HT2B,SB200646,anxiolytic,5-HT2C,neurons,SB 200646,dopaminergic,SB-200646
- Urea, N-(1-methyl-1H-indol-5-yl)-N'-3-pyridinyl-
- 1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-yl-urea
- N-(1-Methyl-1H-indol-5-yl)-N'-3-pyridinylurea
- N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea
- SB200646HCl
- N-(1-METHYL-1H-INDOL-5-YL)-N'-3-PYRIDINYLUREA HYDROCHLORIDE
- N-(1-METHYL-1H-5-INDOLYL)-N'-(3-PYRIDINYL)UREA HYDROCHLORIDE
- SB 200646 HYDROCHLORIDE
- SB 200646